I like your idea and optimism but currently situation is that factory which built APAS is waiting for orders for 5 years and SP is struggling to go pass the failed cap raise price of 6.8c. Future clients (such as astragenica) are funding the invention otherwise LBT cant afford that piece of work. Potential markets size is of multi billuon dollar and this product is pretty much not loved by many so far so not sure about future because if BC, Thermo and Astragenica cant lift this company then who else can.
Ann: AstraZeneca Partners LBT for APAS Pharma Development, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $21.75M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.6¢ | 1.4¢ | $27.28K | 1.812M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1064357 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 894780 | 2 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| LBT (ASX) Chart |